IGC Pharma (IGC) Other financing activities (2013 - 2023)

IGC Pharma (IGC) has reported Other financing activities for 2 consecutive years, with $3.0 million the latest figure, recorded in Q2 2023.

• In Q2 2023, Other financing activities changed N/A year-over-year to $3.0 million; the TTM figure through Jun 2023 stood at $3.0 million (changed N/A YoY), while the FY2024 annual figure was $500000.0, changed N/A from the prior year.
• Other financing activities advanced to $3.0 million in Q2 2023 per IGC's latest filing, from $21291.0 in the prior quarter.
• Across five years, Other financing activities topped out at $3.0 million in Q2 2023 and bottomed at $3.0 million in Q2 2023.